Company Profiles

driven by the PitchBook Platform

Excelimmune

Excelimmune
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Debt LATEST DEAL TYPE
$6M LATEST DEAL AMOUNT
$14.5M TOTAL AMOUNT RAISED
Description

Operator of a bio-pharmaceutical company designed to leverage the diversity, specificity and power of the human body's natural immune system. The company's pharmaceutical includes discovery and development of antibody combination therapeutics, enabling infectious diseases, protein diseases and cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
1776 Massachusetts Avenue
Lexington, MA 02420
United States

+1 (781) 262-8055
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Excelimmune’s full profile, request a free trial.

Excelimmune Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General 31-Dec-2011 $6M $14.5M Completed Profitable
2. Later Stage VC (Series B) 31-May-2011 00.000 00.000 000.00 Completed Profitable
1. Early Stage VC (Series A) 11-May-2007 $2M $2M $3.19M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Excelimmune Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

Excelimmune Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
David Jeske Angel (individual) Minority 000 0000 000000 0
Greenheart Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0

Excelimmune Executive Team (2)

Name Title Board
Seat
Contact
Info
Thomas Dahl Ph.D Vice President, Product Development
Jason Walsh Chief Financial Officer & Vice President, Corporate Development

Excelimmune Board Members (1)

Name Representing Role Since Contact
Info
Mark De Souza Ph.D Self Director 000 0000